Brief: Chordate Medical Launches Pre-Study For FDA Market Approval In U.S

Chordate Medical Holding AB (publ)

13/10/2021 09:09

Oct 13 (Reuters) - Chordate Medical Holding publ AB
 CMHM.NGM :
    * LAUNCHES PRE-STUDY FOR FDA MARKET APPROVAL IN THE UNITED
STATES
    * PRE-STUDY WILL BEGIN IMMEDIATELY AND CAN BE EXPECTED TO BE
COMPLETED WITHIN Q1 OF 2022

Source text for Eikon:  ID:nBQN6FzJ18 
Further company coverage:  CMHM.NGM 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))